These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6285710)

  • 1. Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses.
    Pagano JS; Datta AK
    Am J Med; 1982 Jul; 73(1A):18-26. PubMed ID: 6285710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir inhibition of Epstein-Barr virus replication.
    Datta AK; Colby BM; Shaw JE; Pagano JS
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5163-6. PubMed ID: 6254061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir.
    Colby BM; Shaw JE; Datta AK; Pagano JS
    Am J Med; 1982 Jul; 73(1A):77-81. PubMed ID: 6285738
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication.
    Colby BM; Shaw JE; Elion GB; Pagano JS
    J Virol; 1980 May; 34(2):560-8. PubMed ID: 6246281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.
    Meng Q; Hagemeier SR; Fingeroth JD; Gershburg E; Pagano JS; Kenney SC
    J Virol; 2010 May; 84(9):4534-42. PubMed ID: 20181711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acyclovir on herpes simplex virus replication in a persistently infected human lymphoblastoid cell line (P3HR-1).
    Shaw JE; Colby BM; Leong J; Bolling TJ
    Am J Med; 1982 Jul; 73(1A):72-6. PubMed ID: 6285737
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines.
    Colby BM; Furman PA; Shaw JE; Elion GB; Pagano JS
    J Virol; 1981 May; 38(2):606-11. PubMed ID: 6264131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine on herpes simplex virus and Epstein-Barr virus in a dually infected human lymphoblastoid cell line.
    van der Horst CM; Lin JC; Raab-Traub N; Smith MC; Pagano JS
    J Virol; 1987 Feb; 61(2):607-10. PubMed ID: 3027389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemistry and mechanism of action of acyclovir.
    Elion GB
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():9-17. PubMed ID: 6313600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.
    Lin JC; Smith MC; Pagano JS
    J Virol; 1984 Apr; 50(1):50-5. PubMed ID: 6321799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of action of acyclovir triphosphate on herpesviral and cellular DNA polymerases.
    Allaudeen HS; Descamps J; Sehgal RK
    Antiviral Res; 1982 Aug; 2(3):123-33. PubMed ID: 6291456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine kinase not required for antiviral activity of acyclovir against mouse cytomegalovirus.
    Burns WH; Wingard JR; Bender WJ; Saral R
    J Virol; 1981 Sep; 39(3):889-93. PubMed ID: 6270357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action and selectivity of acyclovir.
    Elion GB
    Am J Med; 1982 Jul; 73(1A):7-13. PubMed ID: 6285736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug targets in herpes simplex and Epstein Barr Virus infections.
    Billaud G; Thouvenot D; Morfin F
    Infect Disord Drug Targets; 2009 Apr; 9(2):117-25. PubMed ID: 19275700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.
    Cheng YC; Huang ES; Lin JC; Mar EC; Pagano JS; Dutschman GE; Grill SP
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2767-70. PubMed ID: 6302704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
    Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus: inhibition of replication by three new drugs.
    Lin JC; Smith MC; Cheng YC; Pagano JS
    Science; 1983 Aug; 221(4610):578-9. PubMed ID: 6306771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
    Stenberg K; Larsson A; Datema R
    J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
    Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
    Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.